DESANTIS, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 2.820
AS - Asia 1.770
EU - Europa 1.167
SA - Sud America 509
AF - Africa 109
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.382
Nazione #
US - Stati Uniti d'America 2.716
SG - Singapore 748
BR - Brasile 415
CN - Cina 338
IT - Italia 318
HK - Hong Kong 193
RU - Federazione Russa 170
VN - Vietnam 170
DE - Germania 151
SE - Svezia 130
FR - Francia 114
GB - Regno Unito 78
IN - India 59
FI - Finlandia 55
CA - Canada 51
ID - Indonesia 36
IQ - Iraq 33
CI - Costa d'Avorio 31
MX - Messico 31
BD - Bangladesh 30
AR - Argentina 28
ZA - Sudafrica 28
NL - Olanda 26
TR - Turchia 24
ES - Italia 21
JP - Giappone 21
PL - Polonia 19
CO - Colombia 17
VE - Venezuela 17
AT - Austria 15
PK - Pakistan 15
UZ - Uzbekistan 13
LT - Lituania 12
SA - Arabia Saudita 12
TN - Tunisia 12
JO - Giordania 11
MA - Marocco 10
EC - Ecuador 9
MY - Malesia 9
UA - Ucraina 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 7
CL - Cile 7
IE - Irlanda 7
PH - Filippine 7
AU - Australia 6
BE - Belgio 6
PY - Paraguay 6
EG - Egitto 5
KE - Kenya 5
AL - Albania 4
AZ - Azerbaigian 4
CR - Costa Rica 4
KR - Corea 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
BH - Bahrain 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IR - Iran 3
PT - Portogallo 3
TW - Taiwan 3
UY - Uruguay 3
BF - Burkina Faso 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
CD - Congo 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
HT - Haiti 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 6.366
Città #
Ashburn 441
Singapore 429
San Jose 247
Chandler 208
Hong Kong 189
Fairfield 172
Woodbridge 131
Beijing 120
Nyköping 114
New York 95
Los Angeles 89
Seattle 84
Cambridge 81
Bari 75
Houston 71
Wilmington 65
Ann Arbor 60
Council Bluffs 59
Lauterbourg 57
Ho Chi Minh City 56
Dallas 54
Munich 47
Falkenstein 46
São Paulo 44
Helsinki 42
Abidjan 31
Hanoi 29
Jakarta 27
Lawrence 26
Roxbury 26
Frankfurt am Main 25
Rome 25
Brooklyn 24
Chicago 24
Santa Clara 20
Tokyo 20
Dearborn 19
Johannesburg 19
Nanjing 19
Chennai 18
Inglewood 18
Orem 18
Buffalo 17
Des Moines 17
Dong Ket 17
Montreal 17
Toronto 16
Denver 15
Phoenix 15
London 14
Moscow 14
Baghdad 13
Curitiba 13
Rio de Janeiro 13
Haiphong 12
Manchester 12
Marseille 12
Mexico City 12
Warsaw 12
Amman 11
Poplar 11
San Diego 11
Atlanta 10
Boston 10
Grafing 10
Paris 10
Tashkent 10
Bogotá 9
Campinas 9
The Dalles 9
Washington 9
Ankara 8
Dhaka 8
Nuremberg 8
Princeton 8
Stockholm 8
Dublin 7
Guangzhou 7
Guarulhos 7
Hebei 7
Jinan 7
Lahore 7
Turku 7
Amsterdam 6
Belo Horizonte 6
Boardman 6
Brussels 6
Buenos Aires 6
Da Nang 6
Goiânia 6
Jacksonville 6
Kuala Lumpur 6
Manaus 6
Porto Alegre 6
Brasília 5
Istanbul 5
Jeddah 5
Milan 5
Nairobi 5
Pune 5
Totale 4.009
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 216
Isolation and characterization of neural stem cells from dystrophic mdx mouse 200
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 184
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 182
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 181
Microenvironment drug resistance in multiple myeloma: Emerging new players 171
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 171
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 156
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 155
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 154
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 151
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 150
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 146
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 137
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 132
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 131
Diabetes and alzheimer’s disease: Might mitochondrial dysfunction help deciphering the common path? 124
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)) 118
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 117
ROLE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND CORRELATION WITH VASCULAR STIFFNESS AND ORGAN DAMAGE 113
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 111
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress 111
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 107
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 106
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 105
Two-year follow-up after drug desensitization in mucopolysaccharidosis 103
A Challenging Case of Visceral Leishmaniasis 103
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 100
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 99
The role of SIRT6 in tumors 96
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 94
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 91
Antiangiogenic drugs as chemosensitizers in hematological tumors 91
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 86
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 85
Genomic profiling at a single center cracks the code in inborn errors of immunity 85
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 81
Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation. 79
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 78
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 78
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 78
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 77
Epigenetic regulation of angiogenesis in tumor progression 76
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 76
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments 76
Changes in Lipids in Granulomatosis with Polyangiitis Relates to Glucocorticoids and History of Hypertension 75
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 75
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 67
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 66
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value 65
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation 63
Correlation between atrial cardiomyopathy and predictive biomarkers of cryptogenic stroke in primary and secondary prophylaxis: potential role of endothelial progenitor cell (EPCs) dysfunction 60
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies 59
Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview 59
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases? 58
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 54
GENDER DISPARITIES IN HYPERTENSIVE PATIENTS ACROSS THE LIFETIME: AN AGE-STRATIFIED ANALYSIS 53
Mast Cells and Interleukins 51
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 51
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature 45
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 45
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers 40
null 39
Successful rapid desensitization to zoledronic acid in a multiple myeloma patient 38
Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma 37
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment Horizons 37
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum 36
Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary disease 35
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma 31
Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma 24
"AGLIANICO DEL VULTURE" RED WINE POLYPHENOLIC EXTRACT (RWP) AS DIETARY SUPPLEMENT FOR PREVENTING OBESITY-ASSOCIATED CARDIOMETABOLIC COMPLICATIONS: THE IN VITRO AND IN VIVO PHARMACO-TOXICOLOGICAL PROFILE 22
MTHFR C677T DEFECT INCREASES SERUM HOMOCYSTEINE LEVELS AND ENDOTHELIAL PROGENITOR CELL (EPCs) DYSFUNCTION IN ATRIAL FIBRILLATION PATIENTS 17
PROTECTIVE EFFECTS OF A RED WINE POLYPHENOL EXTRACT OF AGLIANICO DEL VULTURE ON ENDOTHELIAL CELLS AND MACROPHAGES FROM PATIENTS WITH CARDIOMETABOLIC DISEASE 17
ATRIOVENTRICULAR BLOCK AND ZANUBRUTINIB: THE ROLE OF CARDIONEUROABLATION 16
Impact of remote monitoring on well-being, therapeutic adherence, and organ damage evaluation in hypertensive patients: the PROSIT study 15
STATINS CHANGE miRNA EXPRESSION IN CIRCULATING ENDOTHELIAL PROGENITOR CELLS FROM HYPERTENSIVE PATIENTS 12
Totale 6.723
Categoria #
all - tutte 26.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 56 29 34
2021/2022252 11 18 4 10 8 17 14 11 19 26 38 76
2022/2023454 43 78 38 46 35 63 9 56 65 10 9 2
2023/2024277 19 27 17 23 31 105 7 8 0 17 6 17
2024/20251.457 50 24 43 48 52 131 280 153 78 92 177 329
2025/20263.216 457 165 226 380 466 236 371 115 446 354 0 0
Totale 6.723